Overbrook Management Corp’s Champions Oncology CSBR Stock Holding History

Overbrook Management Corp’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-48,488	Closed	-$301K	–	68
2023 Q3	$301K	Hold	48,488	–	–	0.07%	53
2023 Q2	$309K	Hold	48,488	–	–	0.07%	54
2023 Q1	$195K	Sell	48,488 -5,400	-10%	-$23.1K	0.05%	71
2022 Q4	$243K	Hold	53,888	–	–	0.07%	71
2022 Q3	$404K	Sell	53,888 -10,000	-16%	-$83.6K	0.11%	49
2022 Q2	$511K	Hold	63,888	–	–	0.15%	50
2022 Q1	$519K	Sell	63,888 -17,619	-22%	-$141K	0.12%	59
2021 Q4	$681K	Hold	81,507	–	–	0.14%	56
2021 Q3	$832K	Sell	81,507 -13,433	-14%	-$137K	0.18%	47
2021 Q2	$976K	Sell	94,940 -1,700	-2%	-$17.2K	0.2%	46
2021 Q1	$1.09M	Sell	96,640 -4,805	-5%	-$55.8K	0.24%	45
2020 Q4	$1.09M	Sell	101,445 -403	-0.4%	-$4.16K	0.27%	45
2020 Q3	$942K	Sell	101,848 -12,921	-11%	-$115K	0.22%	64
2020 Q2	$1.1M	Buy	+114,769	New	+$978K	0.29%	58

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Overbrook Management Corp's CSBR Position: Q4 2023 in Review

Overbrook Management Corp sold out of Champions Oncology (CSBR) in Q4 2023, closing a stake of 48,488 shares — an estimated $301K sold.

Overbrook Management Corp first reported a position in CSBR in Q2 2020 and held it in 14 quarters. The position peaked at $1.1M in Q2 2020. 23 funds tracked by Wall St. Rank hold CSBR as of Q4 2023.

Overbrook Management Corp reported no remaining Champions Oncology position as of Q4 2023 after selling out during the quarter.
Overbrook Management Corp sold 48,488 Champions Oncology shares in Q4 2023, an estimated $301K.
Overbrook Management Corp first reported a position in Champions Oncology in Q2 2020 and held it in 14 quarters.
Overbrook Management Corp's Champions Oncology position peaked at $1.1M in Q2 2020.
23 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2023.

Based on Overbrook Management Corp's 13F filing for Q4 2023, filed 2 Feb 2024.